Reckitt Benckiser Group (OTCMKTS:RBGLY) Stock Price Crosses Below 200-Day Moving Average of $13.16

Reckitt Benckiser Group plc (OTCMKTS:RBGLY)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $13.16 and traded as low as $11.22. Reckitt Benckiser Group shares last traded at $11.33, with a volume of 700,935 shares traded.

Analysts Set New Price Targets

Separately, BNP Paribas upgraded Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research report on Tuesday, January 9th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $6,996.67.

Reckitt Benckiser Group Stock Up 0.6 %

The firm has a 50 day moving average price of $11.59 and a 200-day moving average price of $13.14.

Reckitt Benckiser Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Monday, June 3rd. Investors of record on Friday, April 12th will be paid a dividend of $0.2701 per share. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.18. The ex-dividend date of this dividend is Thursday, April 11th.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.